1. 123 AZACITIDINE (AZA) COMBINED WITH IDARUBICIN (IDA) IN HIGHER RISK MDS (HRMDS) – RESULTS OF A PHASE I/II STUDY BY THE GFM. Issue 1 (April 2015) Authors: Sebert, M.; Ades, L.; Stamatoullas, A.; Braun, T.; Delaunay, J.; de Renzis, B.; Jeddi, R.; Meddeb, B.; Berger, M. Hunault; Samey, B.; Chermat, F.; Chaffaut, C.; Chevert, S.; Fenaux, P. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION. (April 2015) Authors: Komrokji, R.; Garcia-Manero, G.; Ades, L.; Laadem, A.; Vo, B.; Prebet, T.; Stamatoullas, A.; Boyd, T.; Delaunay, J.; Steensma, D.P.; Sekeres, M.A.; Beyne-Rauzy, O.; Zou, J.; Attie, K.M.; Sherman, M.L.; Fenaux, P.; List, A.F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 148 CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELL UNDER TREATMENT BY LENALIDOMIDE IN NON DEL(5Q) MDS. Issue 1 (April 2015) Authors: Chesnais, V.; Renneville, A.; Toma, A.; Passet, M.; Gauthier, A.; Delaunay, J.; Rose, C.; Stamatoullas, A.; Beyne-Rauzy, O.; Fenaux, P.; Dreyfus, F.; Preudhomme, C.; Fontenay, M.; Kosmider, O. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES. Issue 1 (April 2015) Authors: Campelo, M. Díez; Lorenzo, J.I.; Itzykson, R.; Rojas, S.M.; Berthon, C.; Luño, E.; Beyne-Rauzy, O.; Pérez-Oteyza, J.; Vey, N.; Bargay, J.; Park, S.; Cedena, T.; Bordessoule, D.; Muñoz, J.A.; Gyan, E.; Such, E.; Visanica, S.; Benlloch, L.; de Botton, S.; Hernández-Rivas, J.M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 87 A PHASE II STUDY OF THE EFFICACY AND SAFETY OF AN INTENSIFIED SCHEDULE OF AZACITIDINE IN HIGHER RISK MDS PATIENTS: A STUDY BY THE GFM. (April 2015) Authors: Ades, L.; Guerci-Bresler, A.; Makhoul, P. Cony; Legros, L.; Delaunay, J.; Recher, C.; Sebert, M.; Lejeune, J.; Chevret, S.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices. (1st October 2018) Authors: Kechichian, E.; Ingen‐Housz‐Oro, S.; Sbidian, E.; Hemery, F.; Bernier, C.; Fite, C.; Delaunay, J.; Staumont‐Sallé, D.; Toukal, F.; Dupin, N.; Abasq, C.; Samimi, M.; Picard, C.; Hebert, V.; Prost, C.; Monfort, J.‐B.; Milpied, B.; Wolkenstein, P.; Chosidow, O. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report. (February 2019) Authors: Grossi, O.; Pineau, S.; Sadot-Lebouvier, S.; Hay, B.; Delaunay, J.; Miailhe, A.-F.; Bretonnière, C.; Jeddi, F.; Lavergne, R.A.; Le Pape, P. Journal: Clinical microbiology and infection Issue: Volume 25:Number 2(2019) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis. (1st August 2020) Authors: Chambrelan, E.; Barbarot, S.; Bekel, L.; Poizeau, F.; Mahé, E.; Puzenat, E.; Delaunay, J.; Mallet, S.; Bessis, D.; Maruani, A.; Miquel, J.; Raison‐Peyron, N.; Abasq, C.; Phan, A.; Du Thanh, A.; Kupfer, I.; Bonniaud, B.; Bouzille, G.; Dupuy, A.; Droitcourt, C. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis. (20th March 2020) Authors: Chambrelan, E.; Barbarot, S.; Bekel, L.; Poizeau, F.; Mahé, E.; Puzenat, E.; Delaunay, J.; Mallet, S.; Bessis, D.; Maruani, A.; Miquel, J.; Raison‐Peyron, N.; Abasq, C.; Phan, A.; Du Thanh, A.; Kupfer, I.; Bonniaud, B.; Bouzille, G.; Dupuy, A.; Droitcourt, C. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Expression of spectrin mutations as a function of their topography. (November 1992) Authors: Delaunay, J.; Alloisio, N.; Morlé, L.; Wilmotte, R.; Maréchal, J.; Baklouti, F. Journal: Biochemical Society transactions Issue: Volume 20:Number 4(1992) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗